Clinical Trial Update: An Open Label, Dose Finding Trial of Viagra for the Treatment of Neuropathic Pain (in Diabetes Mellitus) [Phase 4]

View source ↗

Summary

Completion update of an open-label, dose-finding Phase 4 trial evaluating sildenafil (Viagra) for neuropathic pain in diabetes (diabetic neuropathy).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Viagra (Sildenafil)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Diabetic Neuropathy | Phase 4 | Status: COMPLETED